Xenon Pharmaceuticals (XENE) Misses Q2 EPS by 2c

Xenon Pharmaceuticals (NASDAQ: XENE) reported Q2 EPS of ($0.72), $0.02 worse than the analyst estimate of ($0.70).

For earnings history and earnings-related data on Xenon Pharmaceuticals (XENE) click here.

You May Also Be Interested In

• Synopsys upgraded at Piper Sandler on Intel foundry momentum, Apple opportunity
• Bernstein SocGen Reiterates Outperform Rating on Fervo Energy (FRVO)
• Sunstone Hotel Investors to sell Hyatt Regency San Francisco for $279M